» Articles » PMID: 35287380

Feasibility of Cardiac-synchronized Quantitative T and T Mapping on a Hybrid 1.5 Tesla Magnetic Resonance Imaging and Linear Accelerator System

Abstract

Background And Purpose: The heart is important in radiotherapy either as target or organ at risk. Quantitative T and T cardiac magnetic resonance imaging (qMRI) may aid in target definition for cardiac radioablation, and imaging biomarker for cardiotoxicity assessment. Hybrid MR-linac devices could facilitate daily cardiac qMRI of the heart in radiotherapy. The aim of this work was therefore to enable cardiac-synchronized T and T mapping on a 1.5 T MR-linac and test the reproducibility of these sequences on phantoms and between the MR-linac and a diagnostic 1.5 T MRI scanner.

Materials And Methods: Cardiac-synchronized MRI was performed on the MR-linac using a wireless peripheral pulse-oximeter unit. Diagnostically used T and T mapping sequences were acquired twice on the MR-linac and on a 1.5 T MR-simulator for a gel phantom and 5 healthy volunteers in breath-hold. Phantom T and T values were compared to gold-standard measurements and percentage errors (PE) were computed, where negative/positive PE indicate underestimations/overestimations. Manually selected regions-of-interest were used for intra/inter scanner evaluation.

Results: Cardiac-synchronized T and T qMRI was enabled after successful hardware installation on the MR-linac. From the phantom experiments, the measured T/T relaxation times had a maximum percentage error (PE) of -4.4%/-8.8% on the MR-simulator and a maximum PE of -3.2%/+8.6% on the MR-linac. Mean T/T of the myocardium were 1012 34/51 2 ms on the MR-simulator and 1034 42/51 1 ms on the MR-linac.

Conclusions: Accurate cardiac-synchronized T and T mapping is feasible on a 1.5 T MR-linac and might enable novel plan adaptation workflows and cardiotoxicity assessments.

Citing Articles

Evaluation of the impact of cardiac implantable electronic devices on cine MRI for real-time adaptive cardiac radioablation on a 1.5 T MR-linac.

Akdag O, Mandija S, Borman P, Tzitzimpasis P, van Lier A, Keesman R Med Phys. 2024; 52(1):99-112.

PMID: 39365684 PMC: 11700006. DOI: 10.1002/mp.17438.


Precision requirements in stereotactic arrhythmia radioablation for ventricular tachycardia.

Fast M, Lydiard S, Boda-Heggemann J, Tanadini-Lang S, Muren L, Clark C Phys Imaging Radiat Oncol. 2023; 28:100508.

PMID: 38026083 PMC: 10679852. DOI: 10.1016/j.phro.2023.100508.

References
1.
Messroghli D, Moon J, Ferreira V, Grosse-Wortmann L, He T, Kellman P . Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: A consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular.... J Cardiovasc Magn Reson. 2017; 19(1):75. PMC: 5633041. DOI: 10.1186/s12968-017-0389-8. View

2.
Vigen K, Reeder S, Hood M, Steckner M, Leiner T, Dombroski D . Recommendations for Imaging Patients With Cardiac Implantable Electronic Devices (CIEDs). J Magn Reson Imaging. 2020; 53(5):1311-1317. DOI: 10.1002/jmri.27320. View

3.
Qian P, Azpiri J, Assad J, Gonzales Aceves E, Cardona Ibarra C, de la Pena C . Noninvasive stereotactic radioablation for the treatment of atrial fibrillation: First-in-man experience. J Arrhythm. 2020; 36(1):67-74. PMC: 7011819. DOI: 10.1002/joa3.12283. View

4.
Haslbauer J, Lindner S, Valbuena-Lopez S, Zainal H, Zhou H, DAngelo T . CMR imaging biosignature of cardiac involvement due to cancer-related treatment by T1 and T2 mapping. Int J Cardiol. 2018; 275:179-186. DOI: 10.1016/j.ijcard.2018.10.023. View

5.
Cha M, Seo J, Kim H, Kim M, Yoon H, Jo S . Early Changes in Rat Heart After High-Dose Irradiation: Implications for Antiarrhythmic Effects of Cardiac Radioablation. J Am Heart Assoc. 2021; 10(6):e019072. PMC: 8174197. DOI: 10.1161/JAHA.120.019072. View